Indian Overseas Bank cuts 1-month MCLR by 10 bps to 8.20%, effective March 15

Indian Overseas Bank cut the one-month MCLR by 10 basis points to 8.20%, effective March 15, 2026. Q3 net profit rose 56.2% to ₹1,365 crore. Shares rose 0.86% to ₹33.85.

Indian Overseas Bank cut the one-month MCLR by 10 basis points to 8.20%, effective March 15, 2026. Q3 net profit rose 56.2% to ₹1,365 crore. Shares rose 0.86% to ₹33.85.

The Nifty opened with a gap-down of about 190 points but staged a sharp recovery during the early to mid part of the session. However, the rebound proved short-lived as the index failed to hold on to higher levels and…

Sources told CNBC-TV18 that NSE is targeting a valuation above ₹5 lakh crore for its long-awaited IPO, planning to dilute 4–5% via OFS. More details inside.

The speciality chemicals maker said some of its plants have become non-operational due to disruptions in the supply of ammonia, a key raw material, with certain key suppliers invoking the force majeure clause. Shares of Balaji Amines Ltd ended at…

Manorama Industries Ltd plans to raise ₹500 crore via securities issuance, including equity shares and convertible securities. Shares of Manorama Industries Ltd ended lower on Thursday, March 12, by 0.64% at 1,328.60 on the NSE.

The investment will enable the company to obtain around 48 MW of additional renewable power supply for the Bharuch plant, including about 30 MW of round-the-clock power at a 75% capacity utilisation factor. Shares of DCM Shriram Ltd ended at…

Shares of Max Financial Services Ltd ended at ₹1,698.00, down by ₹27.25, or 1.58%, on the BSE.

Stocks fell on March 12 due to West Asia crisis concerns, eroding over ₹40 lakh crore in investor wealth. Adani Enterprises, DLF, and TCS saw significant drops.

Dow Jones Today | US Stock Market LIVE Updates: US stock futures slipped on Thursday (March 12) as oil prices extended gains on concerns over supply disruptions while the Iran war continued.

Nectar Lifesciences Ltd signed a ₹100-crore, 10-year loan deal at 12% interest with subsidiary Avensis Exports to support its corporate needs. Shares of Nectar Lifesciences Ltd ended marginally lower on Thursday, March 12, by 0.61% 11.35 on the NSE.